Biophytis SA Sponsored ADR BPTSY
0.25
0.00
0.00%
as of 24 Sep
- Market cap
- $2.4M
- P/E
- 0.0×
Follow BPTSY
Growth Flags
show if company had growth for consecutive years
| Jun '25 | Dec '24 | Jun '24 | Dec '23 | Older periods | |
|---|---|---|---|---|---|
Current Ratio |
0.35 | 0.25 | 0.41 | 0.72 |
+8 more quarters Free account |
Net Debt/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | |
Debt/Assets |
116.53% | 142.59% | 110.82% | 69.14% | |
Debt/Equity |
(0.99) | (1.01) | (1.50) | (2.13) | |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex/Depreciation |
0.00 | 0.00 | 0.00 | 0.00 | |
Intangible Assets out of Total Assets |
0.39 | 0.38 | 0.29 | 0.22 | |
Share Based Compensation of Revenue |
0.00% | — | 0.00% | — | |
Free Cash Flow per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Cash per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Shareholders Equity per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Free Cash Flow |
(4.19) | (9.35) | (6.41) | (13.93) | |
Working Capital |
(8.11) | (12.64) | (8.99) | (3.80) | |
Capital Expenditures |
— | 0.00 | (0.01) | 0.00 | |
Net Current Asset Value |
(12.04) | (13.72) | (10.11) | (7.57) | |
| Other line items | |||||
Quick Ratio |
0.35 | 0.25 | 0.41 | 0.72 | |
Operating CF per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex per Share |
— | 0.00 | 0.00 | 0.00 | |
Average Receivables |
4.19 | 5.63 | 7.27 | 5.44 | |
Average Payables |
4.28 | 5.97 | 7.39 | 7.42 | |
Average Assets |
11.73 | 15.32 | 22.72 | 27.92 | |
Average Common Equity |
(6.29) | (6.26) | (1.88) | 1.27 | |
Capex to Sales |
— | 0.00 | 0.00 | 0.00 |
Columns are period end dates